8 employees
Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.
2009
$1.5M
from 2 investors over 2 rounds
Bell Biosystems raised $1.5M on September 30, 2012
Investors: TSVC and Band of Angels